IP Library Granted Patent US 8,071,788
Granted Patent B2
US 8,071,788 · App. 12/635,965 · Granted Dec 6, 2011

Method and intermediates for the preparation of derivatives of N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulfonamide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,788
App. No.
12/635,965
Granted
Dec 6, 2011
Kind
B2
Abstract

The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5 -difluorophenyl)methylsulfonamide.

Claims (15)

1. A process for the preparation of [bis(4-chlorophenyl)methyl]amine, comprising:

a) reacting bis(4-chloro-phenyl)methanone and formamide in the presence of a catalyst, magnesium chloride to form N-[bis-(4-chlorophenyl)methyl]formamide; and

b) deformylating N-[bis-(4-chlorophenyl)methyl]formamide in the presence of HCl in methanol to give [bis(4-chlorophenyl)methyl]amine.

2. A process for the preparation of a compound of formula (IV):

wherein

R and R′ represent, independently of each other, one or more hydrogen, halogen, halogen, cyano, nitro, linear or branched alkyl of 1 to 6 carbon atoms, linear or branched alkoxy of 1 to 6 carbon atoms, linear or branched alkyl carboxylate of 1 to 6 carbon atoms, trifluoromethyl or trifluoromethoxy;

comprising the steps of:

a) reacting a compound of formula (VII)

wherein

R and R′ represent, independently of each other, one or more hydrogen, halogen halogen, cyano, nitro, linear or branched alkyl of 1 to 6 carbon atoms, linear or branched alkoxy of 1 to 6 carbon atoms, linear or branched alkyl carboxylate of 1 to 6 carbon atoms, trifluoromethyl or trifluoromethoxy;

with acetonitrile in the presence of formic acid at a temperature in the range of from about 50° C. to about 150° C., to form a compound of formula (VI):

wherein R and R′ are as defined above;

b) heating the compound of formula (VI) in an acidic medium to form a compound of formula (V) or an acid salt thereof:

wherein R and R′ are as defined above; and

c) converting the compound of formula (V) into the compound of formula (IV) in an organic solvent, n-butanol, and in the presence of anhydrous tripotassium phosphate, an additive, sodium iodide, and, where appropriate, optionally in an aqueous phase.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2023
From: OPIANT PHARMACEUTICALS, INC.
To: INDIVIOR UK LIMITED
Reel/Frame 063944/0323 →
RELEASE OF SECURITY INTEREST Recorded Mar 9, 2023
From: PONTIFAX MEDISON FINANCE GP, L.P.
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 062937/0311 →
SECURITY INTEREST Recorded Dec 10, 2020
From: OPIANT PHARMACEUTICALS, INC.
To: PONTIFAX MEDISON FINANCE GP, L.P.
Reel/Frame 054602/0192 →
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →